Cargando…
Type I Saikosaponins A and D Inhibit Osteoclastogenesis in Bone Marrow-Derived Macrophages and Osteolytic Activity of Metastatic Breast Cancer Cells
Many osteopenic disorders, including a postmenopausal osteoporosis and lytic bone metastasis in breast and prostate cancers, are linked with a hyperosteoclast activity due to increased receptor activator of nuclear factor kappa-B ligand (RANKL) expression in osteoblastic/stromal cells. Therefore, in...
Autores principales: | Shin, Ji-Eun, Kim, Hyun-Jeong, Kim, Ki-Rim, Lee, Sun Kyoung, Park, Junhee, Kim, Hyungkeun, Park, Kwang-Kyun, Chung, Won-Yoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393913/ https://www.ncbi.nlm.nih.gov/pubmed/25892999 http://dx.doi.org/10.1155/2015/582437 |
Ejemplares similares
-
Human antigen R-regulated CCL20 contributes to osteolytic breast cancer bone metastasis
por: Lee, Sun Kyoung, et al.
Publicado: (2017) -
Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma
por: Park, Junhee, et al.
Publicado: (2016) -
Artemisia annua extract prevents ovariectomy-induced bone loss by blocking receptor activator of nuclear factor kappa-B ligand-induced differentiation of osteoclasts
por: Lee, Sun Kyoung, et al.
Publicado: (2017) -
Methanol Extract of Holarrhena antidysenterica Inhibits the Growth of Human Oral Squamous Cell Carcinoma Cells and Osteoclastogenesis of Bone Marrow Macrophages
por: Yoon, Heein, et al.
Publicado: (2017) -
15-Deoxy-Δ(12,14)-Prostaglandin J(2) Inhibits Osteolytic Breast Cancer Bone Metastasis and Estrogen Deficiency-Induced Bone Loss
por: Kim, Ki Rim, et al.
Publicado: (2015)